US FDA approves Vemurafenib , a Melanoma Drug
The United States Food and Drug Administration has approved vemurafenib (Zelboraf), a drug designed to treat patients with metastatic melanoma.
Read morevemurafenib
Roche, Daiichi expect early FDA approval for Melanoma Drug Vemurafenib
Information gathered from close sources reveal that the US regulatory agency might approve an oral BRAF inhibitor vemurafenib jointly developed
Read more